Pfizer is shielded from liability, but they are required to disclose known adverse events and the FDA's records demonstrate that Pfizer failed to do so, and they may be held liable, according to Dr. Robert Malone.

Story at-a-glance

>A Freedom of Information Act (FOIA) request by TheBlaze shows Health and Human Services spent $1 billion for a media campaign to build public confidence in, and uptake of, COVID-19 vaccines using mainstream news outlets

>News outlets that did respond to TheBlaze assured them the editorial staff are not influenced by advertising money, but it's not hard to imagine management would not look kindly on editorial staff who write content that doesn't align with the advertising narrative

>Mounting evidence demonstrates why the government is paying for good press since insurance companies reported a rise in all-cause mortality in late 2021

>The first batch of Pfizer documents the FDA used to approve Comirnaty (Pfizer COVID-19 vaccine) were released March 1, 2022; mRNA technology inventor Dr. Robert Malone believes these papers show a break in the indemnification clauses, exposing Pfizer to potential civil and criminal liability

The Department of Health and Human Services (HHS) released information to TheBlaze1 in response to a Freedom of Information Act (FOIA) request. The information showed that the federal government had purchased advertising to the tune of $1 billion taxpayer dollars as part of a media campaign to build vaccine confidence.

HHS2 has billed the campaign as a "national initiative to increase public confidence in, and uptake of, COVID-19 vaccines while reinforcing basic prevention measures such as mask-wearing and social distancing." Data don't support these measures, but the media campaign was likely hiding something more sinister.

HHS Paid News Media to Build Vaccine Confidence

Within the documents sent from HHS, TheBlaze3 found that hundreds of organizations in the news media were paid to produce TV, print, radio and social media advertising timed to coincide with an increasing availability of the genetic therapy shots.